Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States.

Ristola M, Arbeit RD, von Reyn CF, Horsburgh CR Jr.

Biomed Res Int. 2015;2015:713845. doi: 10.1155/2015/713845. Epub 2015 Jun 9.

2.

Long-term persistence of zoster vaccine efficacy.

Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, Betts R, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman CA, Marques A, Toney J, Boardman K, Su SC, Li X, Chan IS, Parrino J, Annunziato P, Oxman MN; Shingles Prevention Study Group.

Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20.

3.

Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation.

Suárez-Fariñas M, Arbeit R, Jiang W, Ortenzio FS, Sullivan T, Krueger JG.

PLoS One. 2013 Dec 27;8(12):e84634. doi: 10.1371/journal.pone.0084634. eCollection 2013.

4.

Campylobacteriosis in urban versus rural areas: a case-case study integrated with molecular typing to validate risk factors and to attribute sources of infection.

Lévesque S, Fournier E, Carrier N, Frost E, Arbeit RD, Michaud S.

PLoS One. 2013 Dec 26;8(12):e83731. doi: 10.1371/journal.pone.0083731. eCollection 2013.

5.

Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.

Lahey T, Czechura T, Crabtree S, Arbeit RD, Matee M, Horsburgh CR, MacKenzie T, Bakari M, Pallangyo K, von Reyn CF.

J Infect Dis. 2013 Nov 15;208(10):1629-33. doi: 10.1093/infdis/jit396. Epub 2013 Aug 1.

6.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW; Shingles Prevention Study Group.

J Infect Dis. 2013 Aug 15;208(4):559-63. doi: 10.1093/infdis/jit182. Epub 2013 Apr 30.

7.

Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania.

Kabali C, Mtei L, Brooks DR, Waddell R, Bakari M, Matee M, Arbeit RD, Pallangyo K, von Reyn CF, Horsburgh CR.

Tuberculosis (Edinb). 2013 Jul;93(4):461-6. doi: 10.1016/j.tube.2013.01.001. Epub 2013 Mar 22.

8.

Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis.

Lahey T, Mackenzie T, Arbeit RD, Bakari M, Mtei L, Matee M, Maro I, Horsburgh CR, Pallangyo K, von Reyn CF.

Clin Infect Dis. 2013 Jan;56(1):151-8. doi: 10.1093/cid/cis798. Epub 2012 Sep 12.

9.

A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.

Noel GJ, Draper MP, Hait H, Tanaka SK, Arbeit RD.

Antimicrob Agents Chemother. 2012 Nov;56(11):5650-4. doi: 10.1128/AAC.00948-12. Epub 2012 Aug 20.

10.

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, Morrison VA, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman C, Marques A, Toney J, Keller PM, Li X, Chan IS, Annunziato P; Shingles Prevention Study Group.

Clin Infect Dis. 2012 Nov 15;55(10):1320-8. doi: 10.1093/cid/cis638. Epub 2012 Jul 24.

11.

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease.

Adams LV, Kreiswirth BN, Arbeit RD, Soini H, Mtei L, Matee M, Bakari M, Lahey T, Wieland-Alter W, Shashkina E, Kurepina N, Driscoll JR, Pallangyo K, Horsburgh CR, von Reyn CF.

J Clin Microbiol. 2012 Aug;50(8):2645-50. doi: 10.1128/JCM.00624-12. Epub 2012 May 30.

12.

New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.

von Reyn CF, Bakari M, Arbeit RD, Lahey T, Ramadhani A, Egwaga S.

Int J Tuberc Lung Dis. 2012 Jun;16(6):718-23. doi: 10.5588/ijtld.11.0444. Epub 2012 Apr 9. Review.

PMID:
22507085
13.

Use of amplified-fragment length polymorphism to study the ecology of Campylobacter jejuni in environmental water and to predict multilocus sequence typing clonal complexes.

Lévesque S, St-Pierre K, Frost E, Arbeit RD, Michaud S.

Appl Environ Microbiol. 2012 Apr;78(7):2470-3. doi: 10.1128/AEM.06527-11. Epub 2012 Jan 20.

14.

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.

Kabali C, von Reyn CF, Brooks DR, Waddell R, Mtei L, Bakari M, Matee M, Pallangyo K, Arbeit RD, Horsburgh CR Jr.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.

PMID:
22008766
15.

Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.

Lahey T, Mitchell BK, Arbeit RD, Sheth S, Matee M, Horsburgh CR, MacKenzie T, Mtei L, Bakari M, Vuola JM, Pallangyo K, von Reyn CF.

PLoS One. 2011;6(7):e22074. doi: 10.1371/journal.pone.0022074. Epub 2011 Jul 20.

16.

Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.

von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T, Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh CR, Pallangyo K.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1087-92. doi: 10.5588/ijtld.10.0517.

PMID:
21740673
17.

Determination of the optimal culture conditions for detecting thermophilic campylobacters in environmental water.

Lévesque S, St-Pierre K, Frost E, Arbeit RD, Michaud S.

J Microbiol Methods. 2011 Jul;86(1):82-8. doi: 10.1016/j.mimet.2011.04.001. Epub 2011 Apr 12.

PMID:
21504767
18.

High-resolution melting system to perform multilocus sequence typing of Campylobacter jejuni.

Lévesque S, Michaud S, Arbeit RD, Frost EH.

PLoS One. 2011 Jan 24;6(1):e16167. doi: 10.1371/journal.pone.0016167.

19.

Hepatitis C pharmacogenetics: state of the art in 2010.

Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, Goldstein DB; Pharmacogenetics and Hepatitis C Meeting Participants.

Hepatology. 2011 Jan;53(1):336-45. doi: 10.1002/hep.24052. Review.

PMID:
21254181
20.

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, Mtei L, Vuola JM, Pallangyo K, von Reyn CF.

Vaccine. 2010 Nov 10;28(48):7652-8. doi: 10.1016/j.vaccine.2010.09.041. Epub 2010 Sep 25.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk